Published August 1, 2014 | Version v1
Journal article

Mixture effects at very low doses with combinations of anti-androgenic pesticides, antioxidants, industrial pollutant and chemicals used in personal care products

  • 1. Institute for the Environment, Brunel University, Kingston Lane, Uxbridge UB8 3PH (United Kingdom)
  • 2. Institute of Chemical Biology, Imperial College London, Exhibition Road, London SW7 2AZ (United Kingdom)

Description

Many xenobiotics have been identified as in vitro androgen receptor (AR) antagonists, but information about their ability to produce combined effects at low concentrations is missing. Such data can reveal whether joint effects at the receptor are induced at low levels and may support the prioritisation of in vivo evaluations and provide orientations for the grouping of anti-androgens in cumulative risk assessment. Combinations of 30 AR antagonists from a wide range of sources and exposure routes (pesticides, antioxidants, parabens, UV-filters, synthetic musks, bisphenol-A, benzo(a)pyrene, perfluorooctane sulfonate and pentabromodiphenyl ether) were tested using a reporter gene assay (MDA-kb2). Chemicals were combined at three mixture ratios, equivalent to single components' effect concentrations that inhibit the action of dihydrotesterone by 1%, 10% or 20%. Concentration addition (CA) and independent action were used to calculate additivity expectations. We observed complete suppression of dihydrotestosterone effects when chemicals were combined at individual concentrations eliciting 1%, 10% or 20% AR antagonistic effect. Due to the large number of mixture components, the combined AR antagonistic effects occurred at very low concentrations of individual mixture components. CA slightly underestimated the combined effects at all mixture ratios. In conclusion, large numbers of AR antagonists from a wide variety of sources and exposure routes have the ability of acting together at the receptor to produce joint effects at very low concentrations. Significant mixture effects are observed when chemicals are combined at concentrations that individually do not induce observable AR antagonistic effects. Cumulative risk assessment for AR antagonists should apply grouping criteria based on effects where data are available, rather than on criteria of chemical similarity. - Highlights: • Mixtures of AR antagonists at low individual concentrations cause complete inhibition. • Concentration addition was an appropriate prediction model for observed effects. • Risk assessment for AR antagonists should use grouping criteria based on effects

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2013.09.008

Additional details

Identifiers

DOI
10.1016/j.taap.2013.09.008;
PII
S0041-008X(13)00408-0;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
278
Journal Issue
3
Journal Page Range
p. 201-208
ISSN
0041-008X
CODEN
TXAPA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47009325
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANDROGENS; ANTIOXIDANTS; CONCENTRATION RATIO; EVALUATION; FILTERS; GENES; IN VITRO; IN VIVO; MIXTURES; PESTICIDES; PYRENE; RECEPTORS; RISK ASSESSMENT; XENOBIOTICS
Descriptors DEC
ANDROSTANES; AROMATICS; CONDENSED AROMATICS; DIMENSIONLESS NUMBERS; DISPERSIONS; HORMONES; HYDROCARBONS; MEMBRANE PROTEINS; ORGANIC COMPOUNDS; PROTEINS; STEROID HORMONES; STEROIDS

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.